Mr. Sammut is Venture Partner, Burrill & Company, a merchant bank and venture capital fund focused on the life sciences. Mr. Sammut has been involved in the creation of nearly 40 biotechnology, Internet, and information technology companies. He is on numerous Boards of Directors and Advisory Boards, including NexMed, Inc. (NASDAQ), Mitsubishi International Corporation, Women's Reproductive Health, and Dynamis Pharmaceuticals.

Mr. Sammut currently holds appointments as a Lecturer at the Wharton School, the Law School and the School of Engineering and Applied Science of the University of Pennsylvania where he teaches a variety of courses on private equity and corporate development. Mr. Sammut has extensive experience in corporate development and corporate venture capital, having served as Vice President of Teleflex Equities, the corporate development and venture capital arm of Teleflex Incorporated and Vice President, S.R.One, Ltd., the venture capital fund operated by SmithKline Beecham.

Mr. Sammut is also an acknowledged leader in the world of academic technology transfer. He was Managing Director of Access Partners, a seed stage venture firm focusing on the formation and funding of life science firms built around university technologies. He has also been Managing Director of the Center for Technology Transfer at the University of Pennsylvania, and held a similar position at Thomas Jefferson University.

He holds graduate and undergraduate degrees in biological sciences and humanities from Villanova University, attended Hahnemann Medical College for two years, and holds an MBA from the Wharton School of the University of Pennsylvania.